Novejshie zarubezhnye i otechestvennye lekarstvennye preparaty: farmakoterapija, farmakodinamika, farmakokinetika (Newest Foreign and Domestic Preparations: Pharmacotherapy, Pharmacodynamics, Pharmacokinetics)最新文献

筛选
英文 中文
Coronavirus infection: principles of ethyotropic chemotherapy 冠状病毒感染:嗜醇化疗原理
O. Zhirnov
{"title":"Coronavirus infection: principles of ethyotropic chemotherapy","authors":"O. Zhirnov","doi":"10.33920/med-06-2003-03","DOIUrl":"https://doi.org/10.33920/med-06-2003-03","url":null,"abstract":"In the development of the infectious process caused by coronaviruses, two stages can be distinguished: early (ethiotropic) and late (pathogenetic). Therapeutic principles depend on these stages. At the first stage, when the virus accumulates, ethiotropic chemotherapeutic drugs suppressing virus reproduction are predominantly used. The article considers 7 major chemotherapeutic approaches aimed at specific targets in the replication of coronaviruses: viral RNA polymerase inhibitors, inhibitors of viral protease Mpro, inhibitors of proteolytic activation of viral protein S, which carries out the virus entry into the target cell, inhibitors of virus uncoating in the intracellular endosomes, exogenous interferon compounds, preparations of natural and recombinant virus neutralizing antibodies, as well as combinations of the above drugs. At the second stage, when the virus multiplication drops down and threatening pathological processes of excessive inflammation, acute respiratory distress syndrome, pulmonary edema, hypoxia and threatening sepsis develop, it is reasonable to realize antipathogenetic approaches, such as extracorporeal blood oxygenation, detoxication, anti-inflammatory and antibacterial therapeutic drugs and measures.","PeriodicalId":220616,"journal":{"name":"Novejshie zarubezhnye i otechestvennye lekarstvennye preparaty: farmakoterapija, farmakodinamika, farmakokinetika (Newest Foreign and Domestic Preparations: Pharmacotherapy, Pharmacodynamics, Pharmacokinetics)","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117159678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controlled and uncontrolled physicochemical quality indicators of 0.9 % sodium chloride of various manufacturers 各厂家0.9%氯化钠受控和非受控理化质量指标
A. Kasatkin, A. Nigmatullina, M. Kopytov
{"title":"Controlled and uncontrolled physicochemical quality indicators of 0.9 % sodium chloride of various manufacturers","authors":"A. Kasatkin, A. Nigmatullina, M. Kopytov","doi":"10.33920/med-06-2003-01","DOIUrl":"https://doi.org/10.33920/med-06-2003-01","url":null,"abstract":"The article presents the results of studies of osmolality and pH of 0,9 % sodium chloride of various manufacturers. To obtain data on the pH value, the data used in the passports are used, and the indicators of its osmolality are de- termined using laboratory tests. 0,9 % sodium chloride from different manufacturers has different pH and osmolality. Knowing the actual values of physico-chemical parameters can increase the accuracy of the results of future clinical studies, which compare the pharmacokinetics and pharmacodynamics of modern plasma-substituting solutions and a solution of 0,9 % sodium chloride.","PeriodicalId":220616,"journal":{"name":"Novejshie zarubezhnye i otechestvennye lekarstvennye preparaty: farmakoterapija, farmakodinamika, farmakokinetika (Newest Foreign and Domestic Preparations: Pharmacotherapy, Pharmacodynamics, Pharmacokinetics)","volume":"203 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132664738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the treatment of dyslipidemia and atherosclerosis 蛋白转化酶枯草杆菌素/酮素9型(PCSK9)抑制剂在治疗血脂异常和动脉粥样硬化中的重要性
M. Maksimov, A. Shikaleva, A. Kuchaeva
{"title":"Importance of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the treatment of dyslipidemia and atherosclerosis","authors":"M. Maksimov, A. Shikaleva, A. Kuchaeva","doi":"10.33920/med-06-2003-04","DOIUrl":"https://doi.org/10.33920/med-06-2003-04","url":null,"abstract":"Representatives of different groups of lipid-lowering drugs may have some differences in the nature and severity of the effect on the blood lipid spectrum. A new class of drugs, PCSK9 inhibitors, whose activity is associated with a protein involved in the control of low density lipoprotein receptors, has recently appeared. In clinical practice, this group is represented by monoclonal antibody preparations evolocumab and alirocumab. PCSK9 inhibitors are promising drugs for use in combination lipid-lowering therapy, which so far, given the results of clinical studies, can be recommended in the third place after statins and ezetimibe. In clinical studies, it was shown that alirocoumab and evolocumab alone or in combination with statins and/or other lipid-lowering drugs significantly reduce cholesterol levels in low density lipoproteins – by an average of 60%, depending on the dose.","PeriodicalId":220616,"journal":{"name":"Novejshie zarubezhnye i otechestvennye lekarstvennye preparaty: farmakoterapija, farmakodinamika, farmakokinetika (Newest Foreign and Domestic Preparations: Pharmacotherapy, Pharmacodynamics, Pharmacokinetics)","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127540899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信